3155 Porter Drive
Computershare Investor Services PLC
It has been active in the stem cell research field since 1994, principally focused on technologies to grow, differentiate, select and purify embryonic stem cells. The company now has a substantial portfolio of patents and patent applications within these areas. These include technologies to permit the generation and genetic selection of unlimited quantities of highly purified stem cells and their differentiated progeny for use in genetic, pharmacological and toxicological screens. Moreover, these technologies can be utilised to provide pure populations of appropriate cell types for transplantation therapies.
SCS prides itself with the relationship it has with its academic partners which has placed SCS at the forefront of embryonic stem cell research. Stem Cell Sciences has a long established track record in securing research and licensing deals with International Biotechnology and Pharmaceutical companies.
Latest Press Release -
In April 2009, the operations of Stem Cell Sciences plc were acquired by StemCells, Inc., a clinical-stage biotechnology company focused on the research, development and commercialization of products derived from stem cell technologies. Read full release
|Annual Report 2006 in PDF||31/12/2006||6/02/2007|
|Annual Report 2005 in PDF||31/12/2005||29/03/2006|
|Interim Results 2007 in PDF *||30/06/2007||30/08/2007|
|Interim Results 2006 in PDF||30/06/2006||15/09/2006|